Expand IPSC Menu
IPSC MENU

IPSC Stock Summary and Trading Ideas (Century Therapeutics | NASDAQ:IPSC)

Charts for Today's Stock Price and Implied Volatility in Century Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for IPSC by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Century Therapeutics (IPSC) Frequently Asked Questions

What does Century Therapeutics do?

Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.

What symbol and exchange does Century Therapeutics shares trade?

Century Therapeutics trades on the NASDAQ stock market under the symbol IPSC.

What is Century Therapeutics stock price doing today?

As of July 30, 2026, IPSC stock price climbed to $2.19 with 558,181 million shares trading.

What is Century Therapeutics's Beta?

IPSC has a beta of 2.24, meaning it tends to be more sensitive to market movements. IPSC has a correlation of 0.07 to the broad based SPY ETF.

How much is Century Therapeutics worth?

IPSC has a market cap of $394.98 million. This is considered a Small Cap stock.

What is the highest and lowest price Century Therapeutics traded in the last 3 year period?

In the last 3 years, IPSC traded as high as $5.51 and as low as $.34.

What are the top ETFs holding Century Therapeutics?

The top ETF exchange traded funds that IPSC belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

Is Century Therapeutics (IPSC) a good investment?

IPSC has outperformed the market in the last year with a price return of +274.9% while the SPY ETF gained +17.9%. However, in the short term, IPSC had mixed performance relative to the market. It has underperformed in the last 3 months, returning -0.5% vs +4.5% return in SPY. But in the last 2 weeks, IPSC shares have fared better than the market returning +0.9% compared to SPY -1.7%.

What are the support and resistance levels for Century Therapeutics (IPSC)?

IPSC support price is $1.94 and resistance is $2.10 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IPSC shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes